Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient
- PMID: 20697161
- PMCID: PMC2941256
- DOI: 10.4103/0256-4947.67087
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient
Abstract
Carbapenemase-producing Klebsiella pneumoniae infections carry serious clinical and infection-control implications. Isolates possessing such hydrolyzing enzymes have been described in the United States and around the world. Besides being resistant to carbapenems, they usually confer resistance to fluoroquinolones, piperacillin-tazobactam, and extended-spectrum cephalosporins. Tigecycline demonstrates in vitro activity against these organisms, but reported resistance raises concern about tigecycline use for these infections. We describe a carbapenemase-producing K pneumoniae evolving resistance to tigecycline in a 75-year-old male after a prolonged stay in a critical care unit.
Figures
References
-
- Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: Molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother. 2005;56:128–32. - PubMed
-
- Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet Oel S. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia. J Coll Physicians Surg Pak. 2009;19:264–5. - PubMed
-
- Bilal NE, Gedebou M. Clinical and community strains of Klebsiella pneumoniae: Multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci. 2000;57:185–91. - PubMed
-
- El-Khizzi NA, Bakheshwain SM. Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J. 2006;27:37–40. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
